Minh Diem Vu

OX40 costimulation turns off Foxp3+ Tregs

Minh Diem Vu, Xiang Xiao, Wenda Gao et al. · Blood · 2007 · 413 citations · Full text

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Anja Seckinger, Jose Antonio Delgado, Samuel Moser et al. · Cancer Cell · 2017 · 305 citations · Full text

Hematological Malignancy, Cancer Immunosurveillance, Multiple Myeloma Treatment +8

NK cells promote transplant tolerance by killing donor antigen-presenting cells

Guang Yu, Xuemin Xu, Minh Diem Vu et al. · The Journal of Experimental Medicine · 2006 · 271 citations · Full text

Cell Therapy, Immunology, Nk Cells +16

RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents

Daigen Xu, Yong Kim, Jennifer Postelnek et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 140 citations

Critical, but Conditional, Role of OX40 in Memory T Cell-Mediated Rejection

Minh Diem Vu, Michael R. Clarkson, Hideo Yagita∥ et al. · The Journal of Immunology · 2006 · 125 citations · Full text